Moloney Securities Asset Management, LLC Ginkgo Bioworks Holdings, Inc. Transaction History
Moloney Securities Asset Management, LLC
- $666 Million
- Q2 2024
A detailed history of Moloney Securities Asset Management, LLC transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Moloney Securities Asset Management, LLC holds 20,000 shares of DNA stock, worth $165,200. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,000
Previous 20,000
-0.0%
Holding current value
$165,200
Previous $23,000
73.91%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding DNA
# of Institutions
263Shares Held
912MCall Options Held
1.04MPut Options Held
2.23M-
Viking Global Investors LP143MShares$1.18 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA139MShares$1.15 Billion0.0% of portfolio
-
Baillie Gifford & CO134MShares$1.11 Billion0.04% of portfolio
-
Anchorage Capital Group, L.L.C. New York, NY69.9MShares$577 Million7.28% of portfolio
-
Black Rock Inc. New York, NY42MShares$347 Million0.0% of portfolio
About Ginkgo Bioworks Holdings, Inc.
- Ticker DNA
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,287,779,968
- Market Cap $10.6B
- Description
- Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...